Oncology Room
In this room you can find updates and expert discussions in oncology.
Abemaciclib not recommended for advanced breast cancer
Treatment will be removed from the CDF on publication of the final guidance if the draft recommendation does not change following public consultation.
#VisualAbstract: ENESTnd: Frontline nilotinib therapy shows improvement in long-term efficacy outcomes for patients in the chronic phase of newly diagnosed chronic myeloid leukemia
Trifluridine–tipiracil not recommended for metastatic gastric cancer or gastro-oesophageal junction adenocarcinoma
Rifluridine–tipiracil does not meet NICE's criterion to be considered a life-extending treatment at the end of life.
